Caprock Group, Inc. Renovo Rx, Inc. Transaction History
Caprock Group, Inc.
- $4.51 Billion
- Q4 2025
A detailed history of Caprock Group, Inc. transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Caprock Group, Inc. holds 63,940 shares of RNXT stock, worth $47,955. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,940Holding current value
$47,955% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RNXT
# of Institutions
33Shares Held
8.14MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD2.62MShares$1.96 Million0.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.61MShares$1.2 Million0.0% of portfolio
-
Bank Of The West975KShares$731,2500.27% of portfolio
-
Awm Investment Company, Inc. New York, NY864KShares$647,8420.14% of portfolio
-
Bleichroeder LP New York, NY539KShares$403,9650.18% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $6.8M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...